Sign In
Media & Investors
Skip Navigation LinksSanten > Europe > Media & Investors > News > Santen Oy will receive a new Managing Director and Chairman of the Board of Directors
Contact
Santen Pharmaceutical welcomes your inquiries and opinions.

Santen Oy will receive a new Managing Director and Chairman of the Board of Directors

12/15/2015

​Santen Oy's Board of Directors has chosen Ms. Katri Outinen, PhD (Pharm) Vice President of Quality Compliance, to become Santen Oy's new Managing Director. She will start in the new position in the beginning of the new fiscal year, as of 1 April 2016. Santen Oy's current Managing Director, Commercial Counsellor Jyrki Liljeroos will start as the Chairman of the Board of Directors at the same time. The change above is subject to Ltd. approval.

 

Katri has a long-term and wide experience in pharmaceutical industry. She knows both Santen and its business thoroughly. "Katri is the best possible successor of my work", says Jyrki who has served Santen 19 years as Managing Director.

 

As the Chairman of the Board of Directors, Jyrki will be responsible for the liabilities and duties prescribed by the Limited Liability Companies Act. He will also continue cultivating Santen Oy's external partnership and stakeholder relations.